Estimating the long-term health outcomes of treatment with lecanemab in early Alzheimer's disease: a modelling study
{{output}}
Aims: To assess the long-term effects of lecanemab plus standard of care (SoC) compared with SoC alone in a cohort of patients with early Alzheimer's disease (AD; mild cognitive impairment [MCI] due to AD, or mild AD dementia) u... ...
